🔎 Trials Near Me

Akèy › Obèsite › Texas › Grand Prairie

Etid klinik pou Obèsite nan Grand Prairie, TX

13 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Grand Prairie (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • Epic Medical Research, DeSoto · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, DeSoto · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Ap rekriteFaz 3
  • Epic Medical Research - DeSoto, DeSoto · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3
  • AURORA-1 Clinical Site, DeSoto · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, DeSoto · 14 mi lwen
  • AURORA-2 Clinical Site, Waxahachie · 26 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Dallas Heart and Vascular Consultants, Duncanville · 8 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, DeSoto · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Epic Medical Research - Red Oak, DeSoto · 14 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, DeSoto · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284875

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Ap rekriteFaz 3
  • Epic Medical Research - DeSoto, DeSoto · 14 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Aug 27, 2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Dallas Heart and Vascular, Duncanville · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Etid Obèsite nan lòt vil

Lòt etid nan Grand Prairie

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.